(Q56837997)

1 July 2019

title

Effect of aspirin in pregnant women is dependent on increase in bleeding time. (English)

1 reference

1 July 2019

1 reference

1 reference

1 reference

1

1 reference

1 July 2019

author name string

A Flahault

2

1 reference

1 July 2019

M Beaufils

3

1 reference

1 July 2019

E Verdy

4

1 reference

1 July 2019

S Uzan

5

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

1 July 2019

American Journal of Obstetrics and Gynecology

published in

1 reference

1 July 2019

volume

180

1 reference

1 July 2019

issue

1 Pt 1

1 reference

1 July 2019

page(s)

135-140

1 reference

1 July 2019

Prevention of pre-eclampsia by early antiplatelet therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Low-dose aspirin therapy to prevent preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Aspirin and Prevention of Preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Neonatal mortality rate: Relationship to birth weight and gestational age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Uteroplacental Doppler and aspirin therapy in the prediction and prevention of pregnancy complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

A critical reappraisal of the bleeding time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased platelet turnover in a patient with previous recurrent pre-eclampsia and failure of aspirin therapy. Case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970163-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(99)70163-8

1 reference

1 July 2019

PubMed ID

9914592

1 reference

1 July 2019